Evidence map›Paper›PMID 8840782›Full record

ReviewMicrobiological reviews1996

Virus-encoded superantigens.

B T Huber, P N Hsu, N Sutkowski

Open access · diamondAbstract readReview
In one paragraph

Review in Microbiological reviews, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Superantigens and SARS-CoV-2.Pathogens (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Review
  6. Review
  7. Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

B T HuberDepartment of Pathology, Tufts University School of Medicine, Boston, MA 02111, USA. bhuber@opal.tufts.edu
P N Hsu
N Sutkowski
Tufts University · US

Funding

B LYMPHOCYTES--DIFFERENTIATION AND TRIGGERINGR37AI014910 · NIAID · TUFTS UNIVERSITY BOSTON · PI HUBER, BRIGITTE T. · 1994 to 2003
$1.8M
RESEARCH TRAINING IN RHEUMATOLOGY AT NEW ENGLAND MEDICALT32AR007570 · NIAMS · TUFTS MEDICAL CENTER · PI MCALINDON, TIMOTHY E · 1991 to 2005
$1.0M
NIAID NIH HHS R37-AI14910NIAMS NIH HHS 5T32 AR07570-04NIDDK NIH HHS 1P30DK39428
6 · The paper itself

Abstract

Superantigens are microbial agents that have a strong effect on the immune response of the host. Their initial target is the T lymphocyte, but a whole cascade of immunological reactions ensues. It is thought that the microbe engages the immune system of the host to its own advantage, to facilitate persistent infection and/or transmission. In this review, we discuss in detail the structure and function of the superantigen encoded by the murine mammary tumor virus, a B-type retrovirus which is the causative agent of mammary carcinoma. We will also outline what has more recently become known about superantigen activity associated with two human herpesviruses, cytomegalovirus and Epstein-Barr virus. It is likely that we have only uncovered the tip of the iceberg in our discovery of microbial superantigens, and we predict a flood of new information on this topic shortly.

Indexed as

AnimalsAntigens, ViralCytomegalovirusHerpesvirus 4, HumanHumansMammary Tumor Virus, MouseMiceRabies virusSuperantigensAntigens, ViralSuperantigens

Identifiers

PMID8840782
PMCPMC239452
OpenAlexW2159873694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.